2020
DOI: 10.1007/s00415-020-09873-6
|View full text |Cite
|
Sign up to set email alerts
|

Expansion of the dimensions in the current management of acute ischemic stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 50 publications
0
18
0
Order By: Relevance
“…The fi ndings of the current study, consistent with the results of previous research, highlight the multifaceted nature of stroke HCPs' experiences. [4] Understanding and evaluating the educational needs of HCPs regarding stroke is essential to establish benefi cial interdisciplinary training. In addition, evaluating the standards and elements of stroke care, as carried out by HCPs in the emergency, facilitates achieving better health outcomes for stroke patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The fi ndings of the current study, consistent with the results of previous research, highlight the multifaceted nature of stroke HCPs' experiences. [4] Understanding and evaluating the educational needs of HCPs regarding stroke is essential to establish benefi cial interdisciplinary training. In addition, evaluating the standards and elements of stroke care, as carried out by HCPs in the emergency, facilitates achieving better health outcomes for stroke patients.…”
Section: Discussionmentioning
confidence: 99%
“…[2] Regardless of major improvements in its management over the last few decades, stroke is still a deadly disease that is on the rise because of an aging population worldwide and the epidemiological transition in LMICs, and one of these countries is Jordan. [3,4] Approximately 12% of the total deaths in Jordan result from stroke, and it is the third leading cause of death in the country. [5] The burden of stroke is expected to continuously increase in the future in Jordan because of the expected demographic changes.…”
Section: Introductionmentioning
confidence: 99%
“…Tissue-plasminogen activator remains the only effective drug approved by the United States Food and Drug Administration for the treatment of strokes ( 4 , 5 ). Since tissue-plasminogen activator is recommended to be administered within 4.5 h due to the relatively short half-life (3–4.5 min) ( 6 , 7 ), many patients cannot receive timely and efficient treatment. Therefore, the prevention and treatment of stroke require further investigation.…”
Section: Introductionmentioning
confidence: 99%
“…In the wake of the first NMDA antagonist failures, academic and industry investigators met to devise guidelines for improving the testing of candidate neuroprotective treatments in animal models and human trials (Stroke Therapy Academic Industry Roundtable, 1999;Fisher et al, 2009). Vitally, in the interim stroke-is-untreatable nihilism has departed from medicine, as both medical (tissue plasminogen activator, tPA) thrombolysis and, more recently, endovascular thrombectomy improve outcomes in selected patients, even if the latter is delayed up to 24 h after stroke onset (Malik et al, 2020). Major hospitals now deploy specialized stroke teams, capable of completing brain imaging and delivering drugs within minutes of a patient's arrival, and emergency medical services are tuned to getting patients to stroke centers as quickly as possible.…”
Section: Blocking Excitotoxicity In the Ischemic Human Brainmentioning
confidence: 99%